Corteva Inc (NYSE:CTVA)
$ 57.48 -0.35 (-0.61%) Market Cap: 40.06 Bil Enterprise Value: 43.04 Bil PE Ratio: 72.76 PB Ratio: 1.62 GF Score: 82/100

Corteva Inc at Credit Suisse Global Basic Materials Conference Transcript

Sep 17, 2020 / 12:45PM GMT
Release Date Price: $29.58 (+1.20%)
Christopher S. Parkinson;dit Suisse AG
CrÃ;Research Division - Director of Equity Research

© -

So entirely coincidentally, next up, we have Corteva, global leader across multiple substrates within the agricultural products in the spectrum, including germplasm, biotech and traits and crop protection chemicals.

And I have the sense we'll be hearing more about their precision agriculture and gene editing, among many of their innovative arenas alike in the future.

Today, I'm very pleased to have with me the CEO, Jim Collins. Jim, thank you very much for joining us. Today, we're going to be doing a quick intro and then a fireside chat format, but please feel free to e-mail me or Bloomberg me with any questions. My e-mail is [email protected]. And with that, Jim, please.

James C. Collins
Corteva, Inc. - CEO & Director

Great. Thanks, Chris, and thanks for the opportunity. It's a real pleasure to participate virtually at the Credit Suisse conference again this year. As we always do, before we start, just a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot